Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
⏸️ Investing
10 top shares to buy in 2017
⏸️ Investing
The hottest news from 2016: What our readers loved
⏸️ Investing
6 growth shares set for a massive 2017
⏸️ Investing
Healthscope Ltd & CSL Limited: Is it time to buy healthcare shares?
⏸️ Investing
Why you should start buying shares today
⏸️ Investing
Why Cochlear Ltd shares are the best present for the kids this Xmas
⏸️ Investing
Why the Airxpanders Inc share price rocketed 28% today
⏸️ Investing
Market Movers: Why these 4 shares are SOARING today
⏸️ Investing
4 easy ways to profit from the falling Australian dollar in 2017
⏸️ Investing
Australian Dollar (A$) plummets: 3 shares to profit now
⏸️ Investing
10 blue-chip shares to benefit from the US rate rise
⏸️ Investing
Debt Binge: Why the CSL Limited share price is plunging
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
